Last update 17 Jul 2025

Chongqing Qiuwen Biotechnology Co. Ltd.

Startups
| Private Company|2017|Chongqing Shi, China

Overview

Tags

Hemic and Lymphatic Diseases
Neoplasms
Herbal medicine

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
no Data
No Data
Disease DomainCount
Hemic and Lymphatic Diseases1
Neoplasms1
Top 5 Drug TypeCount
Herbal medicine1

Related

1
Drugs associated with Chongqing Qiuwen Biotechnology Co. Ltd.
JNSW10032
Target-
Mechanism-
Active Org.
Chongqing Qiuwen Biotechnology Co. Ltd.
Originator Org.
Chongqing Qiuwen Biotechnology Co. Ltd.
Active Indication
Relapsing acute myeloid leukemia
Inactive Indication
Basal Cell Carcinoma [+2]
Drug Highest PhasePhase 1
First Approval Ctry. / Loc.-
First Approval Date-
1
Clinical Trials associated with Chongqing Qiuwen Biotechnology Co. Ltd.
CTR20222344
/ RecruitingPhase 1
JNSW10032 治疗急性骨髓性白血病的安全性、药代动力学和药效动力学的 I 期临床研究
[Translation] Phase I clinical study of the safety, pharmacokinetics and pharmacodynamics of JNSW10032 in the treatment of acute myeloid leukemia
100 Clinical Results associated with Chongqing Qiuwen Biotechnology Co. Ltd.
Login to view more data
0 Patents (Medical) associated with Chongqing Qiuwen Biotechnology Co. Ltd.
Login to view more data
100 Deals associated with Chongqing Qiuwen Biotechnology Co. Ltd.
Login to view more data
100 Translational Medicine associated with Chongqing Qiuwen Biotechnology Co. Ltd.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 23 Jun 2026

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Phase 1
1
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
JNSW10032
Relapsing acute myeloid leukemia
More
Phase 1
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free